Vidac Pharma picks Strasbourg affiliate for Quest for Health accelerator

Vidac Pharma Holdings said its planned French affiliate, Eutopos Pharma, has been selected for Quest for Health in Strasbourg, a move the company says will support its European expansion and clinical development efforts. The selection gives Vidac access to a biotech hub in the BioValley region spanning France, Germany and Switzerland.

Why it matters: - Eutopos Pharma gives Vidac Pharma a base in continental Europe as the group tries to widen its research, clinical and business development footprint. - The Strasbourg move places Vidac inside a cross-border biotech cluster that connects companies with researchers, investors and potential partners. - Vidac also wants the new affiliate to support oncology and onco-dermatology programs and future technology platforms.

What happened: - Vidac Pharma Holdings said its planned French affiliate, Eutopos Pharma, was selected to join Quest for Health in Strasbourg, France. - Quest for Health is one of Europe’s healthcare and life sciences innovation accelerators. - The selection is part of Vidac Pharma Group’s plan to establish Eutopos Pharma as its French affiliate and European platform. - The company plans to base Eutopos Pharma in Strasbourg.

The details: - Eutopos Pharma is expected to focus on research and development, clinical trials, business development, strategic partnerships and licensing opportunities. - Vidac said the affiliate will also help advance innovative therapeutic technologies. - Dr. Séverine Sigrist has been selected as the proposed chief executive officer of Eutopos Pharma. - Dr. Max Herzberg, chairman and chief executive officer of Vidac Pharma Group, is expected to chair the board of directors and strategic committee once the company is established. - Vidac said Sigrist would lead the Strasbourg operation after the affiliate is formally set up and approved. - Sigrist has worked in biotechnology entrepreneurship, technology transfer and company building, and has founded and led biotech companies. - She has also helped build collaborations between academia and industry in French and European biotechnology. - Quest for Health is located in the BioValley ecosystem spanning France, Germany and Switzerland. - The accelerator gives participating companies access to scientific expertise, industrial partners, investors and innovation infrastructure. - Quest for Health said it currently supports 25 biotech companies and 60 HealthTech startups. - The accelerator said it operates with 10 partners across France, Germany, Switzerland and Belgium.

Between the lines: - The move signals a push by Vidac to anchor more of its European strategy in a recognized regional biotech network. - Choosing Strasbourg and Quest for Health suggests Vidac is seeking proximity to collaborators, capital and clinical-development support rather than building in isolation. - The announcement also frames Eutopos Pharma as a vehicle for future strategic partnerships and licensing deals, not just a local office.

What's next: - Vidac said Eutopos Pharma’s formal establishment remains subject to completion of corporate setup and necessary approvals. - If finalized, Sigrist is expected to run the Strasbourg affiliate’s European activities. - Vidac said it expects the new structure to support longer-term growth and development programs across Europe.

The bottom line: - Vidac Pharma is using Eutopos Pharma and Quest for Health to build a stronger European operating base for pipeline development and partnerships.